OME Care

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources. Find sources: "OME Care" – news · newspapers · books · scholar · JSTOR (November 2018) (Learn how and when to remove this message) This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (November 2018) (Learn how and when to remove this message) (Learn how and when to remove this message)

OME Care (formerly Pathway Genomics) is a privately held global medical diagnostic and homecare company headquartered in San Diego, California. The company specializes in at-home genetic testing and uses artificial intelligence to provide insights for both consumers and physicians. OME Care’s testing services cover a range of conditions including obesity, cardiac health, inherited diseases, and drug responses.

OME Care operates a clinical laboratory that is accredited by the College of American Pathologists (CAP) and meets the requirements of the Clinical Laboratory Improvement Amendments (CLIA).

In 2014, Pathway Genomics, the company’s predecessor, announced a partnership with IBM Watson Group. This collaboration led to the development of a mobile application, named OME, which uses IBM Watson’s technology to offer users personalized health and wellness information based on their health history.

In January 2019, Pathway Genomics was acquired by OME Wellness, which subsequently rebranded the company as OME Care.

OME Care’s key executives include:

• Michael Nova, M.D.: Chief Innovation Officer and Founder.
• Michael H. Cox: CIPP (Certified Information Privacy Professional) and consultant with Privacy SoCal.

• Genetic counseling
• Genomic counseling